Literature DB >> 4630478

Bacterial infection in cystic fibrosis.

J R May, N C Herrick, D Thompson.   

Abstract

Entities:  

Mesh:

Year:  1972        PMID: 4630478      PMCID: PMC1648413          DOI: 10.1136/adc.47.256.908

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


× No keyword cloud information.
  9 in total

1.  Cystic fibrosis of the pancreas.

Authors:  P A DI SANT AGNESE
Journal:  Am J Med       Date:  1956-09       Impact factor: 4.965

2.  The bacteriology of chronic bronchitis.

Authors:  J R MAY
Journal:  Lancet       Date:  1953-09-12       Impact factor: 79.321

3.  Liquefaction of sputum for bacteriological examination.

Authors:  G A RAWLINS
Journal:  Lancet       Date:  1953-09-12       Impact factor: 79.321

4.  Precipitins to Klebsiella and other enterobacteria in the serum of patients with chronic respiratory disorders.

Authors:  M W Burns
Journal:  Lancet       Date:  1968-02-24       Impact factor: 79.321

5.  Haemophilus influenzae precipitins in the serum of patients with chronic bronchial disorders.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1967-02-18       Impact factor: 79.321

6.  Precipitins to pneumococcal C-substance polysaccharide in the serum of patients with chronic bronchial disorders.

Authors:  M W Burns
Journal:  Lancet       Date:  1968-02-03       Impact factor: 79.321

7.  Bacterial precipitins in serum of patients with cystic fibrosis.

Authors:  M W Burns; J R May
Journal:  Lancet       Date:  1968-02-10       Impact factor: 79.321

8.  Bronchial infection in cystic fibrosis.

Authors:  J R May; D E Roberts
Journal:  Lancet       Date:  1969-03-22       Impact factor: 79.321

9.  Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71.

Authors:  M B Mearns; G H Hunt; R Rushworth
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

  9 in total
  28 in total

1.  Vaccine strategies against cystic fibrosis pathogens.

Authors:  Vincent Le Moigne; Jean-Louis Gaillard; Jean-Louis Herrmann
Journal:  Hum Vaccin Immunother       Date:  2016-03-03       Impact factor: 3.452

Review 2.  Cystic fibrosis. Infection and immunity to Staphylococcus aureus and Haemophilus influenzae.

Authors:  D P Greenberg; H R Stutman
Journal:  Clin Rev Allergy       Date:  1991 Spring-Summer

3.  A Comparison between Two Pathophysiologically Different yet Microbiologically Similar Lung Diseases: Cystic Fibrosis and Chronic Obstructive Pulmonary Disease.

Authors:  Daniel E Fenker; Cameron T McDaniel; Warunya Panmanee; Ralph J Panos; Eric J Sorscher; Carleen Sabusap; John P Clancy; Daniel J Hassett
Journal:  Int J Respir Pulm Med       Date:  2018-11-29

4.  Chemoprophylaxis of respiratory infections.

Authors:  J Batten
Journal:  Postgrad Med J       Date:  1976-09       Impact factor: 2.401

5.  Infective respiratory exacerbations in young adults with cystic fibrosis: role of viruses and atypical microorganisms.

Authors:  E L Ong; M E Ellis; A K Webb; K R Neal; M Dodd; E O Caul; S Burgess
Journal:  Thorax       Date:  1989-09       Impact factor: 9.139

6.  Antigenic characterization of the oligosaccharide portion of the lipooligosaccharide of nontypable Haemophilus influenzae.

Authors:  C C Patrick; A Kimura; M A Jackson; L Hermanstorfer; A Hood; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1987-12       Impact factor: 3.441

7.  Bacterial flora of respiratory tract in patients with cystic fibrosis, 1950-71.

Authors:  M B Mearns; G H Hunt; R Rushworth
Journal:  Arch Dis Child       Date:  1972-12       Impact factor: 3.791

8.  Mixed-morphotype broth microdilution susceptibility testing of Pseudomonas aeruginosa from cystic fibrosis patients.

Authors:  K G Van Horn
Journal:  J Clin Microbiol       Date:  1993-02       Impact factor: 5.948

9.  Importance of viruses and Legionella pneumophila in respiratory exacerbations of young adults with cystic fibrosis.

Authors:  J Efthimiou; M E Hodson; P Taylor; A G Taylor; J C Batten
Journal:  Thorax       Date:  1984-02       Impact factor: 9.139

Review 10.  Pneumococcal vaccines for cystic fibrosis.

Authors:  Laura Burgess; Kevin W Southern
Journal:  Cochrane Database Syst Rev       Date:  2016-09-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.